Shenzhen Center For Chronic Disease Control

Shenzhen Center for Chronic Disease Control: A Benchmark for Chronic Disease Prevention and Control in South China, Building a Full-Cycle Service System of “Prevention-Treatment-Management-Rehabilitation”

I. Hospital Overview

Shenzhen Center for Chronic Disease Control (Shenzhen Chronic Disease Prevention and Treatment Hospital) is a Class I public tertiary specialized hospital for chronic disease prevention and treatment directly under the Shenzhen Municipal Health Commission. Originally established as the Shenzhen Tuberculosis Prevention and Treatment Institute in 1985, it consolidated the city's chronic disease prevention resources in 2004 and has progressively developed into the largest comprehensive chronic disease prevention and treatment institution in South China, integrating medical care, prevention, research, and education. The hospital headquarters is located in Xili Subdistrict (Xinwei Community), Nanshan District, with six additional regional prevention centers in Futian, Luohu, Bao'an, and other districts. With a total floor area exceeding 80,000 square meters and 300 open beds (including rehabilitation and nursing beds), it serves over 800,000 chronic disease patients annually. It serves as the “technical leader” and “regional hub” for Shenzhen's chronic disease prevention and control planning.

Guided by the core principle of “prevention-oriented, integrated prevention and treatment,” the hospital undertakes monitoring, early warning, risk assessment, standardized diagnosis and treatment, community management, and health promotion for over 20 chronic diseases across six major categories: hypertension, diabetes, cardiovascular and cerebrovascular diseases, malignant tumors, chronic respiratory diseases, and mental/psychological disorders. It also serves as the “Shenzhen Institute of Chronic Disease Control,” “Guangdong Provincial Technical Guidance Center for Comprehensive Chronic Disease Prevention Demonstration Zones,” and “Shenzhen Training Base for National Basic Public Health Service Projects.” National Basic Public Health Service Project Training Base in Shenzhen. It serves as a ”policy participant,“ ”technology exporter,“ and ”standard leader" in chronic disease prevention within the Guangdong-Hong Kong-Macao Greater Bay Area.

II. Technical Advantages: Prevention-Centered, Building a Closed-Loop Lifecycle Management System

Breaking away from the traditional “disease-centered” model, the Shenzhen Center for Chronic Disease Control focuses on the entire chain of chronic disease management—“early screening, early diagnosis, early treatment, and long-term management”—and has developed three core technical strengths:

• Precision Screening Technology: Independently developed the “Multidimensional Chronic Disease Risk Early Warning Model,” integrated with AI-assisted diagnostic systems (e.g., intelligent CT analysis for pulmonary nodules, diabetic retinopathy detection via fundus photography), elevating early detection rates for hypertension and diabetes to over 85%. • Comprehensive Cancer Screening: Implementing “Five-Cancer Early Screening” (lung, colorectal, upper gastrointestinal, breast, and liver cancers) across all city communities, screening over 200,000 individuals annually with a 40% higher early-stage cancer detection rate compared to traditional methods.

• Standardized Treatment Technologies: Developed the Shenzhen Chronic Disease Clinical Pathway (2024 Edition) and implemented personalized “one patient, one file, one plan” management. Examples include “continuous glucose monitoring + intensive insulin pump therapy” for diabetes patients and “remote home blood pressure monitoring + target organ damage assessment” for hypertension patients. Patient standardized management rates exceed 90% (30% higher than national requirements).

• Smart Management Technologies: Established the “Shenzhen Chronic Disease Big Data Platform” to integrate data from community health centers, hospitals, and medical examination institutions citywide. This enables real-time updates to patient health records, automated alerts for condition changes, and intelligent adjustments to medication regimens. Promoted “Internet+Chronic Disease Management” services, allowing patients to schedule follow-up appointments, access test results, receive medication reminders, and consult doctors online via an app. Annual online service volume exceeded 500,000 visits.

III. Leading Specialties: Focusing on Core Diseases to Build a Regional Prevention and Treatment Hub

The hospital has established a “1+4+N” specialty system (1 Comprehensive Chronic Disease Management Center + 4 Core Specialties + N Distinctive Subspecialties) centered on Shenzhen's prevalent chronic diseases (cardiovascular and cerebrovascular diseases, cancer, metabolic disorders, chronic respiratory diseases). Its core specialty strengths are as follows:

• Cardiovascular and Cerebrovascular Disease Prevention and Treatment Department:

Designated as a Shenzhen Key Medical Specialty, this department excels in standardized diagnosis and treatment of hypertension, coronary heart disease, and stroke. It operates a “Cardiovascular and Cerebrovascular Co-Treatment” joint clinic and established a green channel for “acute myocardial infarction/stroke – community referral – rehabilitation management,” reducing patient recurrence rates by 35%.

• Cancer Prevention and Treatment Department: Demonstration unit for Guangdong Province's Cancer Early Screening, Diagnosis, and Treatment Program. Focuses on high-incidence cancers like lung and colorectal cancer, offering low-dose spiral CT lung cancer screening (95% sensitivity) and colonoscopy colorectal cancer screening (28% early-stage detection rate). Provides comprehensive “screening-diagnosis-surgery-follow-up” management, increasing 5-year survival rates for advanced cancer patients by 20%.

• Metabolic Diseases Department: Shenzhen Endocrine and Metabolic Disease Prevention Center. Offers comprehensive treatment for metabolic disorders, including diabetes, obesity, and hyperlipidemia through “continuous glucose monitoring + visceral fat assessment + nutritional intervention.” Equipped with insulin pumps and continuous glucose monitors (CGM), the program has achieved over 75% glycated hemoglobin target attainment among diabetic patients.

• Chronic Respiratory Diseases Department: As the leading unit of Shenzhen Respiratory Disease Prevention Alliance, it focuses on managing chronic obstructive pulmonary disease (COPD) and bronchial asthma. Services include dynamic lung function monitoring, home oxygen therapy guidance, and respiratory rehabilitation training, reducing COPD acute exacerbation hospitalization rates by 25%.

IV. Department Structure: Integrating Prevention and Treatment to Address Comprehensive Population Health Needs

The hospital's departmental structure embodies a “prevention-clinical-research” tripartite approach, with core departments including:

• Clinical Departments: Comprehensive Chronic Disease Management Center, Cardiovascular and Cerebrovascular Disease Department, Cancer Prevention and Treatment Department, Metabolic Disease Department, Respiratory Disease Department, Mental Health and Psychology Department, Rehabilitation Medicine Department, Nursing Home (care for disabled/partially disabled chronic disease patients).

• Public Health Departments: Disease Surveillance Department (chronic disease epidemiological investigations), Health Promotion Department (community health lectures/physical examinations), Patient Management Department (family doctor contract services), Research and Experimental Center (chronic disease pathogenesis research).

• Medical Technology Departments: Medical Imaging Department (low-dose CT, DR), Laboratory Department (tumor markers, precise blood glucose/lipid testing), Functional Testing Department (pulmonary function, ambulatory blood pressure/ECG), Pathology Department (cancer pathology diagnosis).

V. Medical Equipment: Precisely Tailored to Chronic Disease Management Needs

The hospital is equipped with medical devices highly compatible with chronic disease screening, monitoring, and treatment, balancing precision with accessibility:

• Screening Equipment: Siemens Force Open-Source CT (low-dose lung cancer screening), Fujinon Blue Laser Gastrointestinal Endoscopes (early colorectal cancer screening), Non-Dilating Fundus Camera (diabetic retinopathy screening).

• Monitoring Devices: Continuous Glucose Monitoring (CGM), 24-hour Ambulatory Blood Pressure Monitoring, Pulmonary Function Test (PFT) (Spirometry), Portable Polysomnography (OSA Screening).

• Therapeutic Equipment: Insulin pumps (intensive diabetes management), external counterpulsation devices (coronary heart disease rehabilitation), non-invasive ventilators (acute COPD exacerbation treatment), transcranial magnetic stimulation devices (post-stroke cognitive impairment rehabilitation).

VI. International Patient Services: Personalized Care Tailored to Foreign Chronic Disease Patients

As a designated “Pilot Unit for Foreign Medical Services” in Shenzhen, the hospital offers distinctive services characterized by “convenience, professionalism, and warmth” for foreign chronic disease patients:

• Multilingual Care: Professional interpreters fluent in English, Japanese, and Korean (including medical terminology) accompany outpatient visits, examinations, and hospital stays. Critical medical documents are available in bilingual versions (Chinese-English/Chinese-Japanese/Chinese-Korean).

• Personalized Management: Develops “International Edition” treatment plans for common chronic conditions (e.g., diabetes, hypertension, asthma), tailoring interventions to patients' national lifestyles (e.g., dietary and exercise preferences), and provides an English-language Chronic Disease Self-Management Handbook.

• Convenience Services: Dedicated appointment channel for international patients (specialist consultations arranged within 48 hours); supports foreign currency payments via Visa, MasterCard, and direct billing with international health insurers (MSH, Cigna, etc.); provides airport transfers (private car/appointment-based) and hotel coordination (partnered premium hotels at negotiated rates).

VII. Medical Rankings: Regional Leader and National Benchmark in Chronic Disease Prevention & Management

• National Recognition: Awarded “National Advanced Unit for Comprehensive Chronic Disease Prevention and Control” for five consecutive years; designated as a “Core Institution for Chronic Disease Prevention and Control in South China” in the China Chronic Disease Prevention and Control Development Report (2023); projects including early cancer screening and diabetes management included in the National Health Commission's “Exemplary Cases in Chronic Disease Prevention and Control.”

• Industry Influence: Led the development of local standards, including the Shenzhen Community Management Guidelines for Chronic Diseases and the Home Monitoring Guide for Hypertension Patients, which have been adopted across the Guangdong-Hong Kong-Macao Greater Bay Area. Established the Guangdong-Hong Kong-Macao Chronic Disease Prevention Alliance with The University of Hong Kong-Shenzhen Hospital and Macau Kiang Wu Hospital to facilitate cross-border academic exchanges and technical collaborations.

VIII. International Patient Testimonials: “Professional and Caring Chronic Disease Management Experts”

• Michael (62, Diabetes, USA): “Doctors here don't just focus on blood sugar levels—they taught me to track diet and exercise via my phone. Community nurses visit weekly to monitor blood pressure. This ‘hospital-community-home’ integrated model is more meticulous than anything in the U.S.!”

• Japanese patient Yuki (58, hypertension): “Test reports come with English translations. The doctor used charts to explain my vascular hardening risks and even recommended low-sodium recipes suitable for Japanese diets—truly thoughtful!”

• Singaporean patient Tan (75, COPD): “During non-invasive ventilator therapy, nurses taught me daily breathing exercises. Upon discharge, they provided an English-language manual for my portable oxygen concentrator, enabling proper management back home.”

IX. Contact Information, Address, and Transportation Routes

• Headquarters Address: No. 10, Wenyuan Road, Xinwei Community, Xili Subdistrict, Nanshan District, Shenzhen (near Xili University Town).

• Consultation Hotline: 0755-86001234 (Main Switchboard); 0755-86001666 (International Patient Service Line).

• Transportation Routes:

• Subway: Exit B at Xili Lake Station (Line 7), then walk approximately 1 km (15 minutes); Exit D at Tanglang Station (Line 5), transfer to Bus M313 for direct access.

• Bus: Direct access via “Chronic Disease Prevention and Control Center Station” (M299, M313, M459); “Xili Hospital Station” (Routes 37, 54, 237), 8-minute walk.

• Driving: On-site parking available (Fee: ¥10 for first hour, ¥3 per subsequent hour). During peak hours (8:30-11:00), advance parking reservation is recommended.

Conclusion: Shenzhen Center for Chronic Disease Control, guided by its mission to “Safeguard Quality of Life,” has become a trusted “health steward” for chronic disease patients in South China through its comprehensive “Prevention-Treatment-Management-Wellness” service model. Whether for residents or international friends, the center illuminates the path to long-term health for chronic disease patients with professional medical expertise, meticulous management, and warm humanistic care.

Document dated 2025-09-15 22:03 Modify